Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial

Autor: Zhao, Hong, Zhang, Chi, Zhu, Qi, Chen, Xianxiang, Chen, Guilin, Sun, Wenjin, Xiao, Zuohan, Du, Weijun, Yao, Jing, Li, Guojun, Ji, Yanhua, Li, Niuniu, Jiang, Yujin, Wang, Ying, Zeng, Qingjin, Li, Wei, Gong, Beilei, Chang, Xianyou, Zhu, Feng, Jiang, Xiufeng, Li, Jiawen, Wu, Zhao, Liu, Yingxia, Peng, Peng, Wang, Guiqiang
Zdroj: In International Immunopharmacology August 2021 97
Databáze: ScienceDirect
Externí odkaz: